Literature DB >> 7728624

Mast cell distribution and neutral protease expression in acute and chronic allergic conjunctivitis.

S M Baddeley1, A S Bacon, J I McGill, S L Lightman, S T Holgate, W R Roche.   

Abstract

Allergic eye disease has a variety of clinical manifestations including seasonal atopic conjunctivitis (SAC), perennial atopic conjunctivitis (PAC), atopic keratoconjunctivitis (AKC), and atopic blepharoconjunctivitis (ABC). We have investigated the number, distribution and protease expression of mast cells in normal and diseased conjunctiva with the use of immunohistochemistry in water-miscible resin sections. The median mast cell densities in normal subjects were 17 mm-2 in the bulbar substantia propria and 9 mm-2 in tarsal substantia propria. Mast cells were absent from the normal conjunctival epithelium at both sites. Mast cell densities were increased in the bulbar substantia propria in SAC, AKC and ABC. Tarsal substantia propria showed a significant increase in mast cells in ABC and AKC disease states. Mast cells express a range of proteases which varies according to their anatomic site. Mast cells in connective tissue are described to contain tryptase, chymase, cathepsin-G and carboxypeptidase-A, whereas mucosal mast cells contain only tryptase. In the diseased conjunctiva there was a marked reduction in proteases other than tryptase in the intraepithelial mast cells. There were also significant reductions in protease expression other than tryptase in the bulbar substantia propria in AKC and ABC. There appear to be specific alterations in the distribution of mast cells in the sub-categories of allergic eye disease. The distinction between mucosal and connective tissue mast cell phenotypes is not clear-cut and may depend on the functional state of the mast cells in relation to the microenvironment.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7728624     DOI: 10.1111/j.1365-2222.1995.tb01001.x

Source DB:  PubMed          Journal:  Clin Exp Allergy        ISSN: 0954-7894            Impact factor:   5.018


  7 in total

Review 1.  Ocular mast cells. Characterization in normal and disease states.

Authors:  E B Cook; J L Stahl; N P Barney; F M Graziano
Journal:  Clin Rev Allergy Immunol       Date:  2001-04       Impact factor: 8.667

2.  Mast cells, disease and gastrointestinal cancer: A comprehensive review of recent findings.

Authors:  Kyle Hodges; Lindsey Kennedy; Fanyin Meng; Gianfranco Alpini; Heather Francis
Journal:  Transl Gastrointest Cancer       Date:  2012-02-08

Review 3.  The central role of conjunctival mast cells in the pathogenesis of ocular allergy.

Authors:  Andrea Leonardi
Journal:  Curr Allergy Asthma Rep       Date:  2002-07       Impact factor: 4.919

4.  Constitutive expression of functionally active protease-activated receptors 1 and 2 in human conjunctival epithelial cells.

Authors:  Timothy J Nickel; Mohammad H Kabir; Jaya Talreja; Daniel J Stechschulte; Kottarappat N Dileepan
Journal:  Mediators Inflamm       Date:  2006       Impact factor: 4.711

5.  Mast cell gastritis: children complaining of chronic abdominal pain with histologically normal gastric mucosal biopsies except for increase in mast cells, proposing a new entity.

Authors:  Fatemeh E Mahjoub; Fatemeh Farahmand; Zahra Pourpak; Hoda Asefi; Zahra Amini
Journal:  Diagn Pathol       Date:  2009-10-03       Impact factor: 2.644

Review 6.  Plasmacytoid dendritic cells in the eye.

Authors:  Arsia Jamali; Brendan Kenyon; Gustavo Ortiz; Abdo Abou-Slaybi; Victor G Sendra; Deshea L Harris; Pedram Hamrah
Journal:  Prog Retin Eye Res       Date:  2020-07-24       Impact factor: 21.198

7.  Expression of IL-33 in ocular surface epithelium induces atopic keratoconjunctivitis with activation of group 2 innate lymphoid cells in mice.

Authors:  Yasutomo Imai; Yuka Hosotani; Hiroto Ishikawa; Koubun Yasuda; Makoto Nagai; Orie Jitsukawa; Fumi Gomi; Kenji Nakanishi; Tomohiro Yoshimoto; Takahiro Nakamura; Kiyofumi Yamanishi
Journal:  Sci Rep       Date:  2017-08-30       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.